Large randomized controlled trials show that 2026% of semaglutide users report constipation, making it a common but not universal side effect
A new study, which appeared in The condition, called nonarteritic anterior ischemic optic neuropathy (NAION), affects around The new study finds that people with diabetes who were prescribed semaglutide which is marketed as Ozempic and Wegovy, among other names were more than four times more likely to develop NAION compared with people with diabetes on other medications
Dombrowski SU, Knittle K, Avenell A, et al
employers with 500 or more employees and 64% of employers with 20,000 or more workers cover them compared with 2023, according to Mercers annual survey of employer-sponsored health plans
Essential stimulus for continued muscle growth
But the GLP-1 telehealth landscape is complicated, and the gap between marketing promises and reality can be uncomfortably wide